ESR1 and breast carcinoma: Soto-Cerrato et al. observed potently cytotoxic activity of PG in both estrogen receptor-positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines and suggested PG as an interesting and potent new pro-apoptotic agent for the treatment of breast cancer despite the presence of multidrug resistance transporter molecules [122,123].